Xolair Makes Milk Allergy Tx More Tolerable

SAN DIEGO (MedPage Today) -- Giving omalizumab (Xolair) around the start of oral immunotherapy for milk allergy improved safety, a randomized trial confirmed.
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news